T S Poet

Characterization of the in vitro kinetic interaction of chlorpyrifos-oxon with rat salivary cholinesterase: a potential biomonitoring matrix.

A A Kousba, Charles Timchalk, T S Poet, 2003, Toxicology.

Derivation of a human equivalent concentration for n-butanol using a physiologically based pharmacokinetic model for n-butyl acetate and metabolites n-butanol and n-butyric acid.

H J Clewell, H A Barton, R A Corley, 2005, Toxicological sciences : an official journal of the Society of Toxicology.

Monte Carlo analysis of the human chlorpyrifos-oxonase (PON1) polymorphism using a physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) model.

C Timchalk, T S Poet, T. Poet, 2002, Toxicology letters.

Physiologically based pharmacokinetic/pharmacodynamic model for the organophosphorus pesticide diazinon.

A A Kousba, C Timchalk, T S Poet, 2004, Neurotoxicology.

Development of a physiologically based pharmacokinetic and pharmacodynamic model to determine dosimetry and cholinesterase inhibition for a binary mixture of chlorpyrifos and diazinon in the rat.

C Timchalk, T S Poet, T. Poet, 2008, Neurotoxicology.

Using physiologically based pharmacokinetic modeling and benchmark dose methods to derive an occupational exposure limit for N-methylpyrrolidone.

C R Kirman, P M Schlosser, C. Kirman, 2016, Regulatory toxicology and pharmacology : RTP.